-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on PTC Therapeutics, Raises Price Target to $109

Benzinga·11/02/2026 18:43:05
Citigroup analyst Eric Joseph maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $108 to $109.